Related Experiment Video
Updated: May 22, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
MMTV-neu mice deficient in STAT1 are susceptible to develop ovarian teratomas
Lára Hannesdóttir1, Nina Daschil, Sonja Philipp
1Division of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Abstract:
Signal transducer and activator of transcription 1 (STAT1) serves in the protection of the organism against pathogens and other harmful insults. It is implicated in innate immune response, immunosurveillance, tumor-suppression, and the response to genotoxic as well as oxidative stress. We report here that 9 of 140 examined STAT1 deficient mouse mammary tumor virus-neu (MMTV-neu) mice developed differentiated ovarian teratomas, which histologically resemble benign dermatoid cysts. Conventional karyotyping revealed diploidy without structural rearrangements of the chromosomes. STAT1 proficient MMTV-neu mice with the same genetic background (FVB/N), and STAT1 deficient C57BL/6 mice failed to develop this type of tumor. This indicates that STAT1 deficiency promotes teratoma formation and this depends on MMTV-neu expression and/or the genetic background. Since ovarian teratomas are considered to develop as a consequence of alterations in the maturation of oocytes and follicular cells, we compared the ovaries from non-tumor bearing STAT1 deficient and proficient MMTV-neu mice. No detectable alterations in the number and proportion of the different follicular developmental stages were detected, implying the absence of non-redundant functions of STAT1 in normal folliculogenesis, as well as in follicular atresia. However, strong staining for STAT1 was detectable in granulosa and theca cells. These results point to a role for STAT1 in protecting from teratoma formation in a later step of tumorigenesis, e.g. by inducing apoptosis and eliminating premature or aberrantly formed follicles which have the potential to transform into teratomas.
Insights
Signal transducer and activator of transcription 1 (STAT1) deficiency promotes ovarian teratoma formation in MMTV-neu mice. STAT1 may protect against teratomas by eliminating aberrant follicles, suggesting a role in later tumorigenesis.
Area of Science:
- Oncology
- Immunology
- Developmental Biology
Background:
- Signal transducer and activator of transcription 1 (STAT1) is crucial for organismal defense against pathogens and stress.
- STAT1 is involved in innate immunity, immunosurveillance, and tumor suppression.
Purpose of the Study:
- To investigate the role of STAT1 deficiency in ovarian teratoma development in MMTV-neu mice.
- To determine if STAT1 impacts oocyte and follicular cell maturation.
Main Methods:
- Examined STAT1 deficient and proficient MMTV-neu mice for teratoma development.
- Performed conventional karyotyping on developed teratomas.
- Compared ovarian morphology and follicular development in STAT1 deficient and proficient mice.
Main Results:
- 9 out of 140 STAT1 deficient MMTV-neu mice developed ovarian teratomas resembling dermatoid cysts.
- Teratomas showed diploidy without chromosomal rearrangements.
- STAT1 deficiency promoted teratoma formation, dependent on MMTV-neu expression and genetic background (FVB/N).
- No alterations in folliculogenesis or atresia were observed in non-tumor bearing mice, despite STAT1 presence in granulosa and theca cells.
Conclusions:
- STAT1 deficiency promotes ovarian teratoma formation in a specific genetic context (MMTV-neu mice, FVB/N background).
- STAT1 is not essential for normal folliculogenesis but likely plays a role in preventing teratoma formation by inducing apoptosis in aberrant follicles during later tumorigenesis stages.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
In-vitro Mutagenesis

